Lee, Massachusetts - Boyd Biomedical announced the opening of a new facility in Waltham, Massachusetts today and a new divisional structure. The Company’s divisions – Design by Boyd, Build by Boyd, and Launch by Boyd – provide an integrated Design, Build, Launch growth platform for biomedical innovators.    

Joseph Ting has been appointed President of the Design by Boyd division, which operates out of a new facility in Waltham, Massachusetts, which the Company moved into at the beginning of the year. The design division provides medical device design and development services to entrepreneurs and companies commercializing novel biomedical devices. Joe is an experienced engineering professional and executive leader with decades of experience in the medical device and biotechnology industries.

The Build by Boyd division will continue operating out of its headquarters in Lee, Massachusetts. The build division is a medical device contract manufacturer with capabilities in stick-to-skin devices, in vitro diagnostics, single-use assemblies, device assemblies, and liquid media applications. Build by Boyd is ISO 13485 certified, and FDA registered as a medical device contract manufacturer. The Company began the build operations in Lee in 1979. 

Michael Fallone has been appointed President of the Launch by Boyd division, which operates out of the Company’s existing facility in Boston, Massachusetts. The launch division is a strategy, creative services, and marketing agency for biomedical innovators. Michael is a well-known strategic advisor and creative leader with decades of experience and a proven history of professional success.

“We’re excited to announce our new Design, Build, Launch divisional structure. This is an important step as we continue our mission to provide the most valuable growth platform of commercialization services to biomedical innovators at any stage or scale.”

STEPHEN BOYD
Chief Executive Officer, Boyd Biomedical

Commercializing biomedical devices is increasingly complex due to fragmented markets, shorter product lifecycles, and soaring costs. The Company’s growth platform helps biomedical innovators navigate this challenging environment. Entrepreneurs and companies can leverage these services to help design, manufacture, and market their products, accelerating their commercialization process.